Matches in SemOpenAlex for { <https://semopenalex.org/work/W2965610414> ?p ?o ?g. }
- W2965610414 endingPage "1129" @default.
- W2965610414 startingPage "1109" @default.
- W2965610414 abstract "The logical research on fundamentally adjusted iron oxide nanoparticles has turned out to expanded in biomedicine because of the improved activity and best biocompatibility. In this present work upgraded bio-restorative and pharmacotherapeutic property of chitosan‑iron oxide nanocomposite, which was set up by eco-friendly in situ substance technique. Characterisation of the synthesised nanocomposite by scanning electron microscopy (SEM), Fourier transform infrared spectroscopy (FTIR), x-ray diffraction,(XRD) and Vibrating test magnetometer (VSM) studies reveals that highly stable spherical, electron-dense core shelled rough particles of 50-60 nm. Particle morphology of the synthesised nanocomposite utilising scanning electron microscopy (SEM) uncovers spherical; thick electron centre shelled harsh particles with the size scope of 50-60 nm. FTIR studies show that the specific interaction of practical gatherings of chitosan with iron oxide nanoparticles. Crystalline phase and magnetisation impact of the composite resolved from XRD and VSM studies. Anti-bacterial activity of the nanocomposite examined against human bacterial pathogens which suggest that the readied nanocomposite successfully restrained the development of the tried bacterial strains by recording maximum zone of inhibition, least minimum inhibition concentration (MIC) and biofilm damage against the both tested strains. 100 μg dosages of nanocomposites recorded 20.0 and 21.0 mm of the zone of inhibition against E. coli and S. aureus respectively. Biofilm restraint was additionally observed to be high in nanocomposite treatment by recording lower optical density of ethanol solubilised biofilm of both tested strains. Anticancer activity was examined against the A549 cell line by the assurance of cell feasibility as opposed to oxidative proteins, articulation example of TNF-α, Bax, PARP qualities and apoptosis. Composite prompted 50% of cytotoxicity at 80 μg/mL unmistakably uncovers cytotoxicity against A549 cells. Nanocomposite treatment revealed a high decrease of cell feasibility at all the fixation and most extreme impact seen in 100 μg. Nanocomposite treated cells demonstrated striking changes in cell morphology, the build-up of atomic material related to trademark changes in against oxidative enzymes, quality articulation design which brought about apoptosis-like necrotic cell death. The present findings would propose the conceivable usage of chitosan‑iron oxide nanocomposite as a viable remedial against safe medication pathogens and malignant growth cells." @default.
- W2965610414 created "2019-08-13" @default.
- W2965610414 creator A5027503079 @default.
- W2965610414 creator A5041070059 @default.
- W2965610414 creator A5046745321 @default.
- W2965610414 creator A5066155056 @default.
- W2965610414 date "2019-10-01" @default.
- W2965610414 modified "2023-10-09" @default.
- W2965610414 title "A green chemistry to produce iron oxide – Chitosan nanocomposite (CS-IONC) for the upgraded bio-restorative and pharmacotherapeutic activities - Supra molecular nanoformulation against drug-resistant pathogens and malignant growth" @default.
- W2965610414 cites W1835729076 @default.
- W2965610414 cites W1963916361 @default.
- W2965610414 cites W1973367843 @default.
- W2965610414 cites W1983093763 @default.
- W2965610414 cites W1983266331 @default.
- W2965610414 cites W1983360834 @default.
- W2965610414 cites W1983878125 @default.
- W2965610414 cites W1988197799 @default.
- W2965610414 cites W1988282587 @default.
- W2965610414 cites W1989293528 @default.
- W2965610414 cites W1991830983 @default.
- W2965610414 cites W1998120973 @default.
- W2965610414 cites W1998259303 @default.
- W2965610414 cites W1998412256 @default.
- W2965610414 cites W2003648205 @default.
- W2965610414 cites W2009420486 @default.
- W2965610414 cites W2009789896 @default.
- W2965610414 cites W2014293823 @default.
- W2965610414 cites W2017167818 @default.
- W2965610414 cites W2020945924 @default.
- W2965610414 cites W2021358274 @default.
- W2965610414 cites W2031743190 @default.
- W2965610414 cites W2056140736 @default.
- W2965610414 cites W2061371203 @default.
- W2965610414 cites W2061948577 @default.
- W2965610414 cites W2063168392 @default.
- W2965610414 cites W2067336707 @default.
- W2965610414 cites W2069134412 @default.
- W2965610414 cites W2071659125 @default.
- W2965610414 cites W2079491533 @default.
- W2965610414 cites W2081612482 @default.
- W2965610414 cites W2084273842 @default.
- W2965610414 cites W2084329490 @default.
- W2965610414 cites W2099753445 @default.
- W2965610414 cites W2106503480 @default.
- W2965610414 cites W2107299572 @default.
- W2965610414 cites W2110116275 @default.
- W2965610414 cites W2114962798 @default.
- W2965610414 cites W2117076592 @default.
- W2965610414 cites W2124190794 @default.
- W2965610414 cites W2124371680 @default.
- W2965610414 cites W2135271382 @default.
- W2965610414 cites W2173249787 @default.
- W2965610414 cites W2173987560 @default.
- W2965610414 cites W2415756582 @default.
- W2965610414 cites W2473570070 @default.
- W2965610414 cites W2508274757 @default.
- W2965610414 cites W2530865780 @default.
- W2965610414 cites W2543678683 @default.
- W2965610414 cites W2556565229 @default.
- W2965610414 cites W2751388768 @default.
- W2965610414 cites W2768020262 @default.
- W2965610414 cites W2770837948 @default.
- W2965610414 cites W2781752432 @default.
- W2965610414 cites W2787041871 @default.
- W2965610414 cites W2792396012 @default.
- W2965610414 cites W2852075290 @default.
- W2965610414 cites W2889133405 @default.
- W2965610414 cites W2902949724 @default.
- W2965610414 cites W2929287167 @default.
- W2965610414 doi "https://doi.org/10.1016/j.ijbiomac.2019.07.158" @default.
- W2965610414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31362021" @default.
- W2965610414 hasPublicationYear "2019" @default.
- W2965610414 type Work @default.
- W2965610414 sameAs 2965610414 @default.
- W2965610414 citedByCount "19" @default.
- W2965610414 countsByYear W29656104142019 @default.
- W2965610414 countsByYear W29656104142020 @default.
- W2965610414 countsByYear W29656104142021 @default.
- W2965610414 countsByYear W29656104142022 @default.
- W2965610414 countsByYear W29656104142023 @default.
- W2965610414 crossrefType "journal-article" @default.
- W2965610414 hasAuthorship W2965610414A5027503079 @default.
- W2965610414 hasAuthorship W2965610414A5041070059 @default.
- W2965610414 hasAuthorship W2965610414A5046745321 @default.
- W2965610414 hasAuthorship W2965610414A5066155056 @default.
- W2965610414 hasConcept C127413603 @default.
- W2965610414 hasConcept C13965031 @default.
- W2965610414 hasConcept C155672457 @default.
- W2965610414 hasConcept C159985019 @default.
- W2965610414 hasConcept C160892712 @default.
- W2965610414 hasConcept C171250308 @default.
- W2965610414 hasConcept C178790620 @default.
- W2965610414 hasConcept C185592680 @default.
- W2965610414 hasConcept C191897082 @default.
- W2965610414 hasConcept C192562407 @default.
- W2965610414 hasConcept C26771246 @default.
- W2965610414 hasConcept C2777230088 @default.
- W2965610414 hasConcept C2777697756 @default.